The Ebola epidemic in the Democratic Republic of Congo has claimed more than 200 lives, with Africa CDC — the health agency of the African Union — reporting 202 deaths from 875 confirmed cases, a mortality rate of around 23 percent. The outbreak, which was declared on 15 May, is the 17th to strike the vast central African country and has yet to reach its peak, according to the Red Cross, which has warned it could take up to a year to contain.
The three affected provinces — Ituri, North Kivu and South Kivu in the country's troubled northeast — have long been afflicted by armed conflict and mass displacement, severely hampering the response. Ituri remains the epicentre, accounting for 799 of the confirmed cases, but health authorities say the situation in North Kivu is particularly alarming. Although North Kivu has recorded only 73 confirmed cases, its case fatality rate stands at 59 percent — far above the national average. Insecurity in the province is preventing health teams from reaching affected populations, conducting prevention work, identifying suspected cases and tracing contacts. Africa CDC has warned that the true number of infections there may already be higher than official figures suggest, and has called on authorities to guarantee safe access for responders.
"What is worrisome for us is the contact tracing status," said Dr Wessam Mankoula of Africa CDC. "Because of security challenges and accessibility of some of the areas for our responders from Africa CDC, WHO and different partners, we still see this contact tracing is low."
A critical complicating factor is the strain of the virus involved. The current outbreak is caused by the Bundibugyo strain of Ebola, for which no approved vaccines or treatments currently exist — unlike the more common Zaire strain, against which licensed vaccines have been deployed in previous outbreaks. In response, the World Health Organization has published its first comprehensive clinical guidelines for managing filovirus diseases, a family that includes all Ebola strains and Marburg virus. The 16 evidence-based recommendations emphasise early supportive care — including fluid management, treatment of shock and monitoring for secondary bacterial infections — as the primary means of improving survival in the absence of specific antivirals.
The outbreak has also crossed into neighbouring Uganda, a landlocked country to the northeast of the DRC, though containment efforts there have so far proved effective. Uganda has recorded 19 confirmed cases, including two deaths, with the majority involving Congolese travellers. The situation underscores both the regional dimensions of the crisis and the urgent need for sustained international support to bolster response capacity inside the DRC itself.